Has Ryan Hickey, MD received payments from drug or device companies?

Yes. Drug and device makers reported $122,033 in general payments to Ryan Hickey, MD across 123 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ryan Hickey, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ryan Hickey, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ryan Hickey, MD

Vascular & Interventional Radiology · New York, NYNPI 1972669265

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (45.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 69.1% of it on its own, with 13 other manufacturers making up the rest. Among vascular & interventional radiology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$122,033in general payments, 2019–2025

Across 123 payments — averaging $992.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$84K
Biocompatibles, Inc.$14K
Biocompatibles UK Ltd$8K
Merck$7K
Medtronic$4K
Dova Pharmaceuticals$2K
plus $3K from 8 others

$41,151in research payments, 2019–2025

Across 4 payments — averaging $10,288 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boston Scientific$24K
Biocompatibles UK Ltd$17K

What the payments were for

Consulting fees$55,64446%
Speaking & faculty fees$52,97343%
Travel & lodging$8,2747%
Food & beverage$5,1424%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	90	$84,375
Biocompatibles, Inc.	9	$14,037
Biocompatibles UK Ltd	3	$7,621
Merck	2	$6,500
Medtronic	4	$3,681
Dova Pharmaceuticals	2	$2,353
Terumo Medical Corporation	2	$1,200
Guerbet LLC	4	$968
Johnson & Johnson	1	$600
Angiodynamics, Inc.	2	$270
Bard Peripheral Vascular, Inc.	1	$141
Inari Medical, Inc.	1	$132
Trisalus Life Sciences, Inc.	1	$129
Siemens Medical Solutions USA, Inc.	1	$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

THERASPHERE-BIO$26,190
TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)$17,181
GENERAL - IO ABLATION$14,750
THERASPHERE$11,500
GENERAL - THERAPIES$9,108
TheraSphere Y90 Glass Microspheres 10 GBq$8,472
GENERAL VASCULAR INTERVENTION$4,750
DOPTELET$2,353
GENERAL - CRYOPLASTY$2,250
Azur CX Detachable$1,200
Lipiodol$943
General - Interventional Oncology$625
NEUWAVE Flex Microwave Ablation System$600
TheraSphere Administration Set$149
AlphaVac$145
CATERPILLAR$141
FLOWTRIEVER CATHETER, S$132
CT THROMBECTOMY SYSTEM KIT$132
TRINAV INFUSION SYSTEM$129

How this compares

$122,033 in reported general payments places this provider in the 90th percentile of 306 vascular & interventional radiology providers in New York.

See all vascular & interventional radiology providers in New York →

Medicare billing

Part B allowed, 2024

$585,899

Medicare patients

187

Services billed

4,703

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in New York

Edward KimNew York$831K
Robert LooksteinNew York$515K
Rahul PatelNew York$275K
Aaron FischmanNew York$240K
Philip MeyersNew York$238K
Abigail FalkNew York$214K
Robert RosenNew York$199K
Asad BaigNew York$137K
Joshua WeintraubNew York$137K
Joseph ShamsNew York$136K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →